Search results for: “biotech”
-
Syncona to sell Clade Therapeutics to Century Therapeutics for $45 million
•
LONDON: Syncona Ltd has signed an agreement for the sale of its portfolio company Clade Therapeutics to Century…
-
Animalcare Group to sell it’s stake in STEM Animal Health for $4.7m
•
LONDON, UK: Animalcare Group plc (AIM: ANCR) has reached agreement in principle to sell its 33.34% equity stake…
-
New Advancements In Weight Loss Medications Are Shifting the Weight Loss Landscape
•
Society’s focus on weight and weight loss dates back centuries, and over the years, the battle against obesity…
-
PanTher Therapeutics appoints John Edwards as Executive Chair
•
PanTher Therapeutics, a pioneer in localized cancer treatment, has announced the appointment of John Edwards as the Executive…
-
Obsidian Therapeutics secures $160.5 million in oversubscribed Series C Funding
•
CAMBRIDGE: Obsidian Therapeutics, Inc., a trailblazer in engineered cell and gene therapies, has successfully completed a $160.5 million…
-
Agronomics invests US$ 10 million in Liberation Labs
•
LONDON, UK: Agronomics (LSE: ANIC) has invested US$ 10 million in its portfolio company Liberation Labs Holding Inc.…
-
Aptamer Group posts loss in the first half FY24
•
LONDON, UK: Aptamer Group plc (AIM: APTA) has released its unaudited interim financial results for the six months…
-
ReNeuron Group to appoint administrators amid financial uncertainty
•
LONDON: ReNeuron Group plc, a pioneering UK-based biotechnology firm specializing in stem cell derived exosome technologies, has announced…
-
BPH Global’s top brass on strategic business tour in Malaysia and China
•
SYDNEY: To bolster its market presence, BPH Global Ltd (ASX: BP8) CEO Matthew Leonard and CFO Chow Yee…
-
Genedrive PLC (LON GDR)
•
GDR 3.38 -0.375 -10.00% : Genedrive PLC – MSN Money Genedrive PLC (LON GDR) is a molecular diagnostics…
-
AstraZeneca enters definitive agreement to acquire Amolyt Pharma for $1.05 billion
•
AstraZeneca announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused…
-
Exopharm set to acquire Tryp Therapeutics
•
SYDNEY, AUSTRALIA: , Exopharm Limited has announced an agreement to acquire all issued capital of Tryp Therapeutics Inc.…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.